This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
MIDLAND, Mich. - The Dow Chemical Company is exiting the peroxymeric chemicals (PXC) business, with production having ceased for most products by October 31, 2006. The exit comes following a period of declining revenue and poor market conditions for these products.
The business will continue offering CYRACURE™ photoinitiators, produced by a third party on Dow's behalf, to support its UV-cure customers. However, all other PXC products will be discontinued, including: CYRACURE and ERL cycloaliphatic epoxides; FLEXOL™ EPO and LOE epoxidized oils; and TONE™ caprolactone monomers and polymers, TONE polyols and TONE m-series caprolactone acrylate.
Share This Story
You must login or register in order to post a comment.
Report Abusive Comment